Interactive Investor
>>

Novacyt SA (LSE:NCYT) Share Price

NCYT

Novacyt SA

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Diagnostics & Research

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: Lab21 Product segment is a developer, manufacturer, and distributor of a large range of protein-based infectious disease IVD products; IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.Novacyt SA develops and markets solutions in medical cytology. It offers portfolio of cancer and infectious disease diagnostics products and services. It has three reportable segment, Cytology, Diagnostics and Molecular Testing.

LSE:NCYT

FR0010397232

GBX

Loading...

Loading Comparison

Latest NCYT News

NCYT Regulatory News